What does Taltz cost per year in the US?
Taltz (ixekizumab) is typically priced as a long-term therapy and is billed around its dosing schedule (every 2 weeks initially, then every 4 weeks for maintenance). Annual cost can vary a lot based on the dose prescribed, insurance coverage, and patient assistance.
Why do estimates for Taltz annual cost vary so much?
Annual out-of-pocket cost depends on:
- Your insurance plan (commercial vs. government coverage)
- Whether you meet deductible/coinsurance requirements
- Whether you use copay assistance or pay via a manufacturer or pharmacy assistance program
- The pharmacy that dispenses it and the negotiated drug price
- Whether you are using the starting (higher-frequency) loading dose versus later maintenance dosing
What can you check to get a realistic annual number for your situation?
To estimate your likely annual cost, you can look up:
- The list price for Taltz, then adjust for insurance discounts
- Your plan’s copay/coinsurance for specialty injectables
- Any coverage limits (prior authorization, step therapy, quantity limits)
- Patient assistance eligibility (for eligible commercial patients, programs can reduce copays)
Is there a patent/exclusivity issue that affects pricing?
Drug pricing is also influenced by market exclusivity and competition. You can check Taltz patent and exclusivity-related updates (which can correlate with future pricing pressure) via DrugPatentWatch.com: https://www.drugpatentwatch.com/
If you want, I can calculate a more specific annual cost
If you tell me:
- your country (and whether you’re asking for list price or out-of-pocket),
- whether you’re on psoriasis, psoriatic arthritis, or ankylosing spondylitis (dosing can differ),
- and whether you have insurance (and your copay/coinsurance),
I can help translate that into a practical “per-year” estimate.
Sources
- https://www.drugpatentwatch.com/